AXIM BIOTECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 13.50 million shares for the 9-month period ending 2022-09-30, per its 10-Q/A filed 2022-11-15.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2022-11-15
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-06-30 was 0.00 shares.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-03-31 was 0.00 shares.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2021-12-31 was 0.00 shares.
- AXIM BIOTECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2020 was 8.30M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2022-09-30 | 13.50M shares 10-Q/A · filed 2022-11-15 | |||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16 | 0.00 shares 10-Q · filed 2022-08-16 | 0.00 shares derived: sum of 3 quarters · filed 2022-11-15 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-23 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-15 | ||
| 2021-12-31 | 0.00 shares derived: 10-Q/A 12 month − 10-Q 9 month · filed 2022-11-15 | 2.96M shares 10-Q/A · filed 2022-11-15 | ||
| 2021-09-30 | 2.96M shares 10-Q · filed 2021-11-22 | |||
| 2020-12-31 | 8.30M shares 10-K/A · filed 2022-04-19 |